PDE5A and neoplasm: The tumor uptake of the chemotherapeutic agent, adriamycin, was selectively increased after oral administration of a PDE5 inhibitor, vardenafil (Levitra), without a significant increase in normal brain, leading to a significantly increased survival of rats bearing 9 L gliosarcoma tumors [68].